Skip to main content
SpringerLink
Log in
Book cover

Praxis der Viszeralchirurgie pp 285–290Cite as

Immun- und Gentherapie bei malignen Erkrankungen

  • Chapter

  • 1279 Accesses

Zusammenfassung

Bei der Immun- und der Gentherapie handelt es sich um neuartige, noch experimentelle Therapieformen. Schwerpunkte der Forschung sind z. Z. noch die Weiterentwicklung der Methoden und die Charakterisierung geeigneter molekularer Zielstrukturen. Daher sind der endgültige Stellenwert dieser Verfahren und ihre jeweiligen Anwendungsbereiche gegenwärtig noch nicht abzusehen. Nachfolgend sollen exemplarisch immun- und gentherapeutische Strategien zur Behandlung maligner Tumoren dargestellt werden.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   269.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Allay JA, Persons DA, Galipeau J, Riberdy JM, Ashmun RA, Blakley RL, Sorrentino BP (1998) In vivo selection of retrovirally transduced hematopoietic stem cells. Nat Med 4: 1136–1143

    Article  CAS  PubMed  Google Scholar 

  • Åman P (1999) Fusion genes in solid tumors. Sem Cancer Biol 9: 303–318

    Google Scholar 

  • Baselga J, Tripathy D, Mendelsohn J et al. (1996) Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol 14: 737–744

    CAS  PubMed  Google Scholar 

  • Bernhard H, Meyerzum Büschenfelde C, Peschel C (2001) Adoptiver Transfer von tumorreaktiven T-Zellen. Onkologe 11: 1196–1201

    Google Scholar 

  • Blattman JN, Greenberg PD (2004) Cancer immunotherapy: a treatment for the masses. Science 305: 200–205

    Article  CAS  PubMed  Google Scholar 

  • Bonini C, Ferrari G, Verzeletti S et al. (1997) HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276: 1719–1724

    Article  CAS  PubMed  Google Scholar 

  • Bouvet M, Ellis LM, Nishizaki M et al. (1998) Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res. 58: 2288–2292

    CAS  PubMed  Google Scholar 

  • Brenner MK, DR Rill, RC Moen, RA Krance, J Mirro Jr, WF Anderson, JN Ihle (1993) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341: 85–86

    Article  CAS  PubMed  Google Scholar 

  • Clayman GL, el-Naggar AK, Lippman SM et al. (1998) Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol 16: 2221–2232

    CAS  PubMed  Google Scholar 

  • Deisseroth AB, Zu Z, Claxton D et al. (1994) Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83: 3068–3076

    CAS  PubMed  Google Scholar 

  • Donk van de NW, de Weerdt O, Veth G et al. (2004) G3139, a Bcl-2 antisense oligodeoxynucleotide, induces clinical responses in VAD refractory myeloma. Leukemia 18: 1078–1084

    PubMed  Google Scholar 

  • Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21: 137–148

    Article  CAS  PubMed  Google Scholar 

  • Finn OJ (2003) Cancer vaccines: between the idea and the reality. Nat Rev Immunol 3: 630–641

    Article  CAS  PubMed  Google Scholar 

  • Freytag SO, Khil M, Stricker H et al. (2002) Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res 62: 4968–4976

    CAS  PubMed  Google Scholar 

  • Hacein-Bey-Abina S, Von Kalle C, Schmidt M et al. (2002) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415–419

    Google Scholar 

  • Heise C, Sampson-Johannes A, Williams A, McCormick F, Von Hoff DD, Kirn DH (1997) ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat Med 3: 639–645

    Article  CAS  PubMed  Google Scholar 

  • Holmgren L, Jackson G, Arbiser J (1998) p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma. Oncogene 17: 819–824

    Article  CAS  PubMed  Google Scholar 

  • Khuri FR, Nemunaitis J, Ganly I et al. (2000) A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 6: 879–885

    Article  CAS  PubMed  Google Scholar 

  • Licht T, Hafkemeyer P (1999) Aktuelle Aspekte der somatischen Gentherapie. Dtsch Med Wochenschr 124: 700–706

    CAS  PubMed  Google Scholar 

  • Licht T, Haskins M, Henthorn P et al. (2002) Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma-chain and multidrug resistance (MDR1) transgenes in canine bone marrow. Proc Natl Acad Sci USA. 99: 3123–3128

    Article  CAS  PubMed  Google Scholar 

  • McLaughlin P, Grillo-Lopez A, Link B et al. (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program. J Clin Oncol 16: 2825–2833

    CAS  PubMed  Google Scholar 

  • Mickisch GH, Licht T, Merlino GT, Gottesman MM, Pastan I (1991) Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: Efficacy, potency and toxicity. Cancer Res 51: 5417–5424

    CAS  PubMed  Google Scholar 

  • Moscow JA, Huang H, Carter C et al. (1999) Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood 94: 52–61

    CAS  PubMed  Google Scholar 

  • Pandha HS, Martin LA, Rigg A, Hurst HC, Stamp GW, Sikora K, Lemoine NR (1999) Genetic prodrug activation therapy for breast cancer: A Phase I clinical trial of erbB-2-directed suicide gene expression. J Clin Oncol 17: 2180–2189

    CAS  PubMed  Google Scholar 

  • Rabbits T (1994) Chromosomal translocations in human cancer. Nature 372: 143–149

    Google Scholar 

  • Rainov NG (2000) A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11: 2389–2401

    Article  CAS  PubMed  Google Scholar 

  • Ram Z, Culver KW, Oshiro EM et al. (1997) Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 3: 1354–136

    Article  CAS  PubMed  Google Scholar 

  • Rehwald, U., Diehl, V., Engert, A (2001) Antikörper, Immuntoxine, Radioimmunkonjugate. Onkologe 11: 1206–1219

    Google Scholar 

  • Rooney CM, Smith CA, Ng CY et al. (1998) Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92: 1549–1555

    CAS  PubMed  Google Scholar 

  • Roth JA, Nguyen D, Lawrence DD et al. (1996) Retrovirus-mediated wildtype p53 gene transfer to tumors of patients with lung cancer. Nat Med 2: 985–991

    CAS  PubMed  Google Scholar 

  • Saltz LB, Meropol NJ, Loehrer PJ Sr, Needle MN, Kopit J, Mayer RJ (2004) Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol 22: 1201–1208

    Article  CAS  PubMed  Google Scholar 

  • Schuler M, Rochlitz C, Horowitz JA et al. (1998) A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum Gene Ther 9: 2075–2082

    CAS  PubMed  Google Scholar 

  • Schuler G, Schuler-Thurner B, Steinman RM (2003) The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 15: 138–147

    Article  CAS  PubMed  Google Scholar 

  • Sosman JA, Unger JM, Liu PY et al., Southwest Oncology Group (2002) Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome. J Clin Oncol 15: 2067–2075

    Google Scholar 

  • Steiner MS, Anthony CT, Lu Y, Holt JT (1998) Antisense c-myc retroviral vector suppresses established human prostate cancer. Hum Gene Ther 9: 747–755

    CAS  PubMed  Google Scholar 

  • Suto R, Tominaga K, Mizuguchi H et al. (2004) Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancer. Gene Ther 11: 187–193

    Article  CAS  PubMed  Google Scholar 

  • Swisher SG, Roth JA, Nemunaitis J et al. (1999) Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst 91: 763–771

    Article  CAS  PubMed  Google Scholar 

  • Tanaka K, Iwakuma T, Harimaya K, Sato H, Iwamoto Y (1997) EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing’s sarcoma and primitive neuroectodermal tumor cells. J Clin Invest 99: 239–247

    CAS  PubMed  Google Scholar 

  • Webb A, Cunningham D, Cotter F et al. (1997) BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet 349: 1137–1141

    Article  CAS  PubMed  Google Scholar 

  • Wei J, Blum S, Unger M et al. (2004) Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell 477–488

    Google Scholar 

Download references

Authors
  1. H. Bernhard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Licht
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Peschel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chirurgische Klinik und Poliklinik, Technische Universität München Klinikum rechts der Isar, Ismaninger Str. 22, 81657, München, Germany

    Jörg Rüdiger Siewert

  2. Zentrum für Operative Medizin I, Klinikum der Philipps-Universität, Baldinger Straße, 35043, Marburg, Germany

    Matthias Rothmund

  3. Medizinische Fakultät der RWTH, Universitätsklinik und Poliklinik, Pauwelsstr. 30, 52057, Aachen, Germany

    Volker Schumpelick

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Bernhard, H., Licht, T., Peschel, C. (2006). Immun- und Gentherapie bei malignen Erkrankungen. In: Siewert, J.R., Rothmund, M., Schumpelick, V. (eds) Praxis der Viszeralchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30036-8_25

Download citation

  • DOI: https://doi.org/10.1007/3-540-30036-8_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21914-9

  • Online ISBN: 978-3-540-30036-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation